Citation Impact
Citing Papers
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Oxygen, oxidative stress, hypoxia, and heart failure
2005
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
2007 Standout
Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling
2005
Angiotensin II acutely decreases myocardial stiffness: a novel AT1, PKC and Na+/H+exchanger‐mediated effect
2006
Albuminuria in Mice after Injection of Antibodies against Aminopeptidase A
2001 StandoutNobel
Acute kidney injury
2012 Standout
Primary Pulmonary Hypertension
2000
Delayed graft function in kidney transplantation
2004 Standout
Selective Aldosterone Blockade Suppresses Atrial Tachyarrhythmias in Heart Failure
2006
Diminished NO generation by injured endothelium and loss of macula densa nNOS may contribute to sustained acute kidney injury after ischemia-reperfusion
2008
Posttranscriptional Compensation for Heterozygous Disruption of the Kidney-Specific NaK2Cl Cotransporter Gene
2002 StandoutNobel
The assessment of refill compliance using pharmacy records: Methods, validity, and applications
1997 Standout
Effects of adriamycin on heart mitochondrial function in rested and exercised rats
1994
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
1995 StandoutNature
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (F e NO ) for Clinical Applications
2011 Standout
Minireview: Computer Simulations of Blood Pressure Regulation by the Renin-Angiotensin System
2003 StandoutNobel
Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation
2015
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Protective Effect of HMG-CoA Reductase Inhibitor on Experimental Renal Ischemia-Reperfusion Injury
2002
Type 2 Diabetes Mellitus and Hypertension
2013
Cellular and molecular pathobiology of pulmonary arterial hypertension
2004 Standout
Uric Acid and Cardiovascular Risk
2008 Standout
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
2016 Standout
Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats.
1995
Subtle Acquired Renal Injury as a Mechanism of Salt-Sensitive Hypertension
2002
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Activation of transcription factors AP-1 and NF-κB in chronic cyclosporine A nephrotoxicity: role in beneficial effects of magnesium supplementation1
2003 StandoutNobel
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Synergistic effect of atorvastatin and Cyanidin-3-glucoside on angiotensin II-induced inflammation in vascular smooth muscle cells
2016
Inhibition of nuclear factor-κB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy
2003 StandoutNobel
Beneficial effects of statins in patients with non-ischemic heart failure
2004
Role of immunocompetent cells in nonimmune renal diseases
2001
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
A Role for Uric Acid in the Progression of Renal Disease
2002 Standout
Differential cardioprotective/cardiotoxic effects mediated by β-adrenergic receptor subtypes
2005 StandoutNobel
Irbesartan
1997
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study
2000
Measurement of patient compliance and the interpretation of randomized clinical trials
1991
Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism
1999
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Interactions between endothelin-1 and the renin–angiotensin–aldosterone system
1999
INHIBITORS OF NADPH OXIDASE REDUCE THE ORGAN INJURY IN HEMORRHAGIC SHOCK
2005
The Multifunctional Fish Gill: Dominant Site of Gas Exchange, Osmoregulation, Acid-Base Regulation, and Excretion of Nitrogenous Waste
2004 Standout
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
Role of cGMP-kinase II in the control of renin secretion and renin expression.
1998
Essential Hypertension, Progressive Renal Disease, and Uric Acid
2005
Type 2 diabetes mellitus
2015 Standout
Reactive oxygen species in hypertension*1An update
2004
Salt Reduction to Prevent Hypertension and Cardiovascular Disease
2020
Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats
1998
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism.
2002 StandoutNobel
Facilitative Urea Transporters
2001
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition
2001
Physiological and Molecular Characterization of Urea Transport by the Gills of the Lake Magadi Tilapia (Alcolapia Grahami)
2001
Extracts Enriched in Different Polyphenolic Families Normalize Increased Cardiac NADPH Oxidase Expression while Having Differential Effects on Insulin Resistance, Hypertension, and Cardiac Hypertrophy in High-Fructose-Fed Rats
2004
Eel urea transporter is localized to chloride cells and is salinity dependent
2001
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
2006 Standout
UT-A2: a 55-kDa urea transporter in thin descending limb whose abundance is regulated by vasopressin
2000
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Nifedipine Prevents Renal Injury in Rats With Chronic Nitric Oxide Inhibition
1995
Oxygen, oxidative stress, hypoxia, and heart failure
2005
Activation of RhoA and Inhibition of Myosin Phosphatase as Important Components in Hypertension in Vascular Smooth Muscle
2003
Activation of NF-κB in Tubular Epithelial Cells of Rats With Intense Proteinuria
2001
Guanylyl Cyclases and Signaling by Cyclic GMP
2000 Standout
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
2000 Standout
PLEIOTROPIC EFFECTS OF STATINS
2004 Standout
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
2005 Standout
Bioactive Compounds and Antioxidant Activity in Different Types of Berries
2015 Standout
Additive Beneficial Effects of Losartan Combined With Simvastatin in the Treatment of Hypercholesterolemic, Hypertensive Patients
2004
Renal Dysfunction Complicating the Treatment of Hypertension
2002
Molecular Characterization of a Urea Transporter in the Gill of the Gulf Toadfish (Opsanus Beta)
2000
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
Ca2+Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase
2003 Standout
Vascular and Metabolic Effects of Combined Therapy With Ramipril and Simvastatin in Patients With Type 2 Diabetes
2005
Aquaglyceroporin AQP9: Solute permeation and metabolic control of expression in liver
2003 StandoutNobel
Sympathetic baroreceptor responses after chronic NG-nitro-L-arginine methyl ester treatment in conscious rats.
1994
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Seasonal variation in blood pressure: Evidence, consensus and recommendations for clinical practice. Consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability
2020
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
2003 Standout
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Aquaporins in the Kidney: From Molecules to Medicine
2002 StandoutNobel
Role of Renal Angiotensin II Type 1 Receptors in the Genesis of Hypertension
2007 StandoutNobel
Works of Bernard Jover being referenced
Nitric Oxide Inhibition and Renal Alterations
2001
Effects of Spironolactone and Fosinopril on the Spontaneous and Chronic Ventricular Arrhythmias in a Rat Model of Myocardial Infarction
2001
Cardiovascular responses to graded treadmill exercise during the development of doxorubicin induced heart failure in rabbits
1990
La restriction sodée prévient le remodelage cardiovasculaire dans l’insulinorésistance chez le rat
2013
Cloning and Characterization of Two New Isoforms of the Rat Kidney Urea Transporter
1999
Endogenous Vasoactive Systems and the Pressor Effect of Acute N ω-Nitro-L-Arginine Methyl Ester Administration
1994
Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist.
1994
Contrasting renal effects of chronic administrations of enalapril and losartan on one-kidney, one clip hypertensive rats
1998
Effect of losartan and enalapril on renal adaptation sodium restriction in rat
1994
Sodium restriction prevents cardiac hypertrophy and oxidative stress in angiotensin II hypertension
2003
Simvastatin Prevents Angiotensin II–Induced Cardiac Alteration and Oxidative Stress
2002
Renal function in one-kidney, one clip sodium-restricted rats
1995
Geographical Variations in Blood Pressure Level and Seasonality in Hemodialysis Patients
2017
Prevention of the Cardiovascular and Renal Effects of Angiotensin II by Endothelin Blockade
1998
[Simvastatin attenuates cardiovascular effects and oxidative stress induced by angiotensin II].
2001
Carbon monoxide increases inducible NOS expression that mediates CO-induced myocardial damage during ischemia-reperfusion
2015
Maintenance of the antihypertensive efficacy of captopril despite consistent reduction in daily dosage.
1982
Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function.
1994
Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade.
1993
Aging and sodium homeostasis.
1992
Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan.
1995